Chemical Biology of Homocysteine Thiolactone and Related Metabolites

Advances in Clinical Chemistry

Volumn 55, Issue , 2011, Pages 81-103

  Jakubowski, Hieronim ^a,b,c   Głowacki, Rafał ^d  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^c POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^d UNIVERSITY OF LODZ   (Poland)

Author keywords

Homocysteine thiolactone; N Homocysteinylated protein; N Homocysteinyl lysine

Indexed keywords

EID: 80052665221     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387042-1.00005-8     Document Type: Chapter

References (92)

1. Butz L.W., du Vigneaud V. The formation of homologue of cysteine by the decomposition of methionine with sulfuric acid. J. Biol. Chem. 1932, 99:135-142.
2. Baernstein H.D. A modification of the method for determining methionine in proteins. J. Biol. Chem. 1934, 106:451-456.
3. Finkelstein J.D. Pathways and regulation of homocysteine metabolism in mammals. Semin. Thromb. Hemost. 2000, 26:219-225.
4. Jakubowski H., Goldman E. Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS Lett. 1993, 317:593-598.
5. Jakubowski H., Zhang L., Bardeguez A., Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ. Res. 2000, 87:45-51.
6. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 1997, 272:1935-1942.
7. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 1999, 13:2277-2283.
8. Jakubowski H., Boers G.H., Strauss K.A. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 2008, 22:4071-4076.
9. Glowacki R., Bald E., Jakubowski H. Identification and origin of Nε-homocysteinyllysine isopeptide in humans and mice. Amino Acids 2010, 39:1563-1569.
10. Za{ogonek}bczyk M., Glowacki R., Machnik A., et al. Elevated levels of N-Hcy-Lysine isopeptide in acute myocardial infarction: links with ADMA formation. Clin. Chem. Lab. Med. 2010, 49:729-735.
11. Jakubowski H. Translational accuracy of aminoacyl-tRNA synthetases: implications for atherosclerosis. J. Nutr. 2001, 131:2983S-2987S.
12. Jakubowski H. Translational incorporation of S-nitroso-homocysteine into protein. J. Biol. Chem. 2000, 275:21813-21816.
13. Mudd S.H., Levy H.L., Kraus J.P. Disorders of transsulfuration. The metbolic & molecular bases of inherited disease 2001, 2007-2056. McGraw-Hill, New York, vol. II. eighth ed. C. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
14. Rosenblatt D., Fenton W.A. Inherited disorders of folate and cobalamin transport and metabolism 2001, 3897-3933. McGraw-Hill, New York, vol. II. eighth ed. C. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
15. Lentz S.R. Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 2005, 3:1646-1654.
16. Smith A.D., Smith S.M., de Jager C.A., et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 2010, 5(1-10):e12244. 10.1371/journal.pone.0012244.
17. Steegers-Theunissen R.P.M., Boers G.H.J., Trijbels F.J.M., Eskes T.K.A.B.N. Neural-tube defects and derangement of homocysteine metabolism. N. Engl. J. Med. 1991, 234:199-200.
18. Ueland P.M., Vollset S.E. Homocysteine and folate in pregnancy. Clin. Chem. 2004, 50:1293-1295.
19. Danese S., Sgambato A., Papa A., et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am. J. Gastroenterol. 2005, 100:886-895.
20. van Meurs J.B.J., Dhonukshe-Rutten R.A.M., Pluijm S.M.F., et al. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 2004, 20:2033-2041.
21. Ji C., Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J. Gastroenterol. 2004, 10:1699-1708.
22. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell. Mol. Life Sci. 2004, 61:470-487.
23. Jakubowski H. Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease. Clin. Chem. Lab. Med. 2005, 43:1011-1014.
24. Jakubowski H. Pathophysiological consequences of homocysteine excess. J. Nutr. 2006, 136:1741S-1749S.
25. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin. Chem. Lab. Med. 2007, 45:1704-1716.
26. Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J. Physiol. Pharmacol. 2008, 59:155-167.
27. Jakubowski H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J. Nutr. 2000, 130:377S-381S.
28. Jakubowski H. Protein N-homocysteinylation: implications for atherosclerosis. Biomed. Pharmacother. 2001, 55:443-447.
29. Jakubowski H. tRNA synthetase editing of amino acids. Encyclopedia of Life Sciences 2005, John Wiley & Sons, Chichester. 10.1038/npg.els.0003933.
30. Jakubowski H. Biosynthesis and reactions of homocysteine thiolactone. Homocysteine in Health and Disease 2001, 21-31. Cambridge University Press, Cambridge. D.W. Jacobson, R. Carmel (Eds.).
31. Jakubowski H. Accuracy of aminoacyl-tRNA synthetases: proofreading of amino acids 2005, 21-31. The aminoacyl-tRNA synthetases, Landes Bioscience/Eureka.com, Georgetown, TX. M. Ibba, C. Francklyn, S. Cusack (Eds.).
32. Jakubowski H. Calcium-dependent human serum homocysteine thiolactone hydrolase: a protective mechanism against protein-N-homocysteinylation. J. Biol. Chem. 2000, 275:3957-3962.
33. Jakubowski H., Ambrosius W., Pratt J.H. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis. FEBS Lett. 2001, 491:35-39.
34. Despons L., Senger B., Jakubowski H., Fasiolo F. Yeast cytoplasmic and mitochondrial methionyl-tRNA synthetases: two structural frameworks for identical functions. J. Mol. Biol. 2001, 311:205-216.
35. Glowacki R., Jakubowski H. Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J. Biol. Chem. 2004, 279:10864-10871.
36. Zimny J., Sikora M., Guranowski A., Jakubowski H. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J. Biol. Chem. 2006, 281:22485-22492.
37. Jakubowski H. Facile syntheses of [35S] homocysteine-thiolactone, [35S] homocysteine, [35S] homocysteine, and [S-nitroso-35S] homocysteine. Anal. Biochem. 2007, 370:124-126.
38. Riegel B., du Vigneaud V. The isolation of homocysteine and its conversion to a thiolactone. J. Biol. Chem. 1935, 112:149-154.
39. Jakubowski H. The determination of homocysteine thiolactone in biological samples. Anal. Biochem. 2002, 308:112-119.
40. Chwatko G., Jakubowski H. The determination of homocysteine-thiolactone in human plasma. Anal. Biochem. 2005, 337:271-277.
41. Dudman N.P., Hicks C., Lynch J.F., Wilcken D.E., Wang J. Homocysteine thiolactone disposal by human arterial endothelial cells and serum in vitro. Arterioscler. Thromb. 1991, 11:663-670.
42. Jakubowski H. Aminoacylation of coenzyme A and pantetheine by aminoacyl-tRNA synthetases: possible link between non-coded and coded peptide synthesis. Biochemistry 1998, 37:5147-5153.
43. du Vigneaud V., Patterson W.I., Hunt M. Opening the ring of the thiolactone of homocysteine. J. Biol. Chem. 1938, 126:217-231.
44. Duerre J., Miller C.H. Preparation of L-homocysteine from L-homocysteine thiolactone. Anal. Biochem. 1966, 17:310-315.
45. Racker E. Metabolism of thiolesters of glutathione. Fed. Proc. 1953, 12:711-715.
46. Gao W., Goldman E., Jakubowski H. Role of carboxy terminal region in proofreading function of methionyl-tRNA synthetase in Escherichia coli. Biochemistry 1994, 33:11528-11535.
47. Jakubowski H. Proofreading in vivo: editing of homocysteine by aminoacyl-tRNA synthetases in Escherichia coli. J. Biol. Chem. 1995, 270:17672-17673.
48. Jakubowski H., Guranowski A. Metabolism of homocysteine-thiolactone in plants. J. Biol. Chem. 2003, 278:6765-6770.
49. Jakubowski H. Mechanism of the condensation of homocysteine thiolactone with aldehydes. Chem. Eur. J. 2006, 12:8039-8043.
50. Jakubowski H. Proofreading in vivo: editing of homocysteine by methionyl-tRNA synthetase in the yeast Saccharomyces cerevisiae. EMBO J. 1991, 10:593-598.
51. Jakubowski H. Proofreading in vivo: editing of homocysteine by methionyl-tRNA synthetase in Escherichia coli. PNAS 1990, 87:4504-4508.
52. Sikora M., Jakubowski H. Homocysteine editing and growth inhibition in Escherichia coli. Microbiology 2009, 155:1858-1865.
53. Law S.K., Dodds A.W. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 1997, 6:263-274.
54. Xu M.Q., Perler F.B. The mechanism of protein splicing and its modulation by mutation. EMBO J. 1996, 15:5146-5153.
55. Porter J.A., Young K.E., Beachy P.A. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996, 274:255-259.
56. Mukai Y., Togawa T., Suzuki T., Ohata K., Tanabe S. Determination of homocysteine thiolactone and homocysteine in cell cultures using high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B 2002, 767:263-268.
57. Chwatko G., Jakubowski H. Urinary excretion of homocysteine-thiolactone in humans. Clin. Chem. 2005, 51:408-415.
58. Deneshvar P., Yazdanpanah M., Cuthbert C., Cole D.E.C. Quantitative assay of plasma homocysteine thiolactone by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2003, 17:358-362.
59. Glowacki R., Bald E., Jakubowski H. An on-column derivatization method for the determination of homocysteine-thiolactone and protein N-linked homocysteine. Amino Acids. 2010, 41:187-194.
60. Jakubowski H., Fersht A.R. Alternative pathways for editing non-cognate amino acids by aminoacyl-tRNA synthetases. Nucleic Acids Res. 1981, 9:3105-3117.
61. Jakubowski H. Aminoacyl thioester chemistry of class II aminoacyl-tRNA synthetases. Biochemistry 1997, 36:11077-11085.
62. Chwatko G., Boers G.H., Strauss K.A., Shih D.M., Jakubowski H. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J. 2007, 21:1707-1713.
63. Perła-Kajan J., Jakubowski H. Paraoxonase 1 protects against protein N-homocysteinylation in humans. FASEB J. 2010, 24:931-936.
64. Suszynska J., Tisonczyk J., Lee H.G., Smith M.A., Jakubowski H. Reduced homocysteine-thiolactonase activity in Alzheimer's disease. J. Alzheimers Dis. 2010, 19:1177-1183.
65. Jakubowski H., Perla-Kajan J., Finnell R.H., et al. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 2009, 23:1721-1727.
66. Gu W., Lu J., Yang G., et al. Plasma homocysteine thiolactone associated with risk of macrovasculopathy in Chinese patients with type 2 diabetes mellitus. Adv. Ther. 2008, 25:914-924.
67. Sikora M., Marczak Ł., Twardowski T., Stobiecki M., Jakubowski H. Direct monitoring of albumin lysine-525 N-homocysteinylation in human serum by liquid chromatography/mass spectrometry. Anal. Biochem. 2010, 405:132-134.
68. Sauls D.L., Lockhart E., Warren M.E., Lenkowski A., Wilhelm S.E., Hoffman M. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 2006, 45:2480-2487.
69. Zang T., Dai S., Chen D., Lee B.W.K., Liu S., Karger B.L., et al. Chemical methods for the detection of protein N-homocysteinylation via selective reactions with aldehydes. Anal. Chem. 2009, 81:9065-9071.
70. Perla-Kajan J., Marczak L., Kajan L., Skowronek P., Twardowski T., Jakubowski H. Modification by homocysteine thiolactone affects redox status of cytochrome c. Biochemistry 2007, 46:6225-6231.
71. Sibrian-Vazquez M., Escobedo J.O., Lim S., Samoei G.K., Strongin R.M. Homocystamides promote free-radical and oxidative damage to proteins. PNAS 2010, 107:551-554.
72. Ferretti G., Bacchetti T., Masciangelob S., Bicchiega V. Effect of homocysteinylation on high density lipoprotein physico-chemical properties. Chem. Phys. Lipids 2010, 163:228-235.
73. Paoli P., Sbrana F., Tiribilli B., et al. Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. J. Mol. Biol. 2010, 400:889-907.
74. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev. 1998, 30:225-243.
75. Stadtman E.R. Protein oxidation and aging. Science 1992, 257:1220-1224.
76. Thomas J.A., Mallis R.J. Aging and oxidation of reactive protein sulfhydryls. Exp. Gerontol. 2001, 36:1519-1526.
77. Smith C.D., Carney J.M., Starke-Reed P.E., et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. PNAS 1991, 88:10540-10543.
78. Oliver C.N., Ahn B.W., Moerman E.J., Goldstein S., Stadtman E.R. Age related changes in oxidized proteins. J. Biol. Chem. 1987, 262:5488-5491.
79. Gladstone I.M., Levine R.L. Oxidation of proteins in neonatal lungs. Pediatrics 1994, 93:764-768.
80. Berlett B.S., Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 1997, 272:20313-20316.
81. Jakubowski H. Homocysteine is a protein amino acid in humans: implications for homocysteine-linked disease. J. Biol. Chem. 2002, 277:30425-30428.
82. Undas A., Brozek J., Jankowski M., Siudak Z., Szczeklik A., Jakubowski H. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler. Thromb. Vasc. Biol. 2006, 26:1397-1404.
83. Jakubowski H. New method for the determination of protein N-linked homocysteine. Anal. Biochem. 2008, 380:257-261.
84. Jakubowski H., Perła-Kaján J., Finnell R.H., et al. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 2009, 23:1721-1727.
85. Uji Y., Motomiya Y., Hanyu N., Ukaji F., Okabe H. Protein-bound homocystamide measured in human plasma by HPLC. Clin. Chem. 2002, 48:941-944.
86. Perna A.F., Satta E., Acanfora F., Lombardi C., Ingrosso D., De Santo N.G. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney Int. 2006, 69:869-876.
87. Yang X., Gao Y., Zhou J., et al. Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease. Clin. Chim. Acta 2006, 364:230-234.
88. Perla-Kajan J., Stanger O., Luczak M., et al. Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomed. Pharmacother. 2008, 62:473-479.
89. Undas A., Perla J., Lacinski M., Trzeciak W., Kazmierski R., Jakubowski H. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004, 35:1299-1304.
90. Undas A., Jankowski M., Twardowska M., Padjas A., Jakubowski H., Szczeklik A. Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men. Thromb. Haemost. 2005, 93:346-350.
91. Glowacki R., Bald E. Fully automated method for simultaneous determination of cysteine, cysteinylglycine, glutathione and homocysteine in plasma by high performance liquid chromatography. J. Chromatogr. B 2009, 877:3400-3404.
92. Bald E., Glowacki R. 2-Chloro-1-methylquinolinium tetrafluoroborate as effective and thiol specific UV-tagging reagent for liquid chromatography. J. Liq. Chromatogr. Rel. Techn. 2001, 24:1323-1339.